Home   >    COVID-19   >   Covid-19 Inhibitors

Chloroquine phosphate

Antimalarial drug
Catalog No. C119-905

For enquiry on all COVID-19 Inhibitors email us at orders@signalchem.com

Catalog No. Pack Size Price (USD)
C119-905-1 1 g $45
C119-905-05 5 g $80
C119-905-BULK BULK Contact Us  


Chloroquine Phosphate is the phosphate salt of chloroquine, a quinoline compound. The compound is used as an effective treatment against malaria caused by Plasmodium falciparum. Researchers are actively investigating this compound against the SARS-CoV-2 and have documented that that chloroquine phosphate may control the infection by promoting a virus-negative conversion and shortening the disease. The molecular studies suggested multiple potential mechanisms employed by the compound, including inhibiting viral endocytosis; limiting inflammatory response, and binding of Sigma 1 receptor to the SARS-CoV-2 Nsp6 protein.**

Antimalarial drug. Inhibits autophagy in a variety of cell lines (1). Induces cell death in breast cancer cell lines and displays antitumor and antimetastatic activity in mouse models of breast cancer (2). Eliminates cancer stem cells via deregulation of Jak2 and DNMT1 (3). Displays synergy when combined with Raf inhibitor, vemurafenib, in brain tumors (4). Cell permeable and active in vivo.


1. HB Frieboes et al. JOP 2014 15:189

2. PD Jiang et al. Biomed. Pharmacother. 2010 64:609

3. DS Choi et al. Stem Cells. 2014 32:2309

4. JM Mulcahy Levy et al. Cancer Discov. 2014 4:773

CAS Registry Number:


Molecular Formula:

C18H26ClN3 · 2H3PO4


White powder

Molecular Weight:



>98% (TLC); NMR (conforms)


May be dissolved in water (25mg/ml)


N4-(7-Chloro-4-quinolinyl)-N1,N1-dimethyl-1,4-pentanediamine, diphosphate

Storage and Stability:

Store desiccated as supplied at ambient temperature for up to 2 years. Store solutions at -20°C for up to 3 months.

Molecular Structure:

Product Datasheets

There are no related publications available for this product.



Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox